Below are examples of 3 patients with locally advanced BCC previously treated with an HHI, who saw tumors shrink (partial response) with treatment. In this trial, 25% (21 out of 84) patients had a partial response with LIBTAYO. Individual patient responses may vary.
Pictured below is a facial lesion of a 77-year-old female patient. The patient had a response that lasted almost 5 months, after which the disease worsened (as shown in the 92-week image, below).
Pictured below is an ear tumor of a 79-year-old male patient.
This patient's response was still ongoing at the time of data collection.
Pictured below is a head lesion of a 66-year-old male patient.
This patient's response was still ongoing at the time of data collection.